Incidence of skeletal muscle disorders after statins' treatment: consequences in clinical and EMG picture.

Objectives: The goal of this clinical trial was to determine the incidence of undesirable side effects, and to ascertain any occurrence of genetic polymorphisms.

Material And Methods: Clinically, we looked for manifestations of a benign myositis and of serious rhabdomyolysis. We observed a group 198 patients treated with statins, primarially fluvastatin and rosuvastatin.